Report #2832446

Received Mar 20, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Female
Age: Age unknown
State: FL
Recovered: Unknown
Vaccinated: Mar 10, 2025
Onset: Mar 10, 2025
Days to onset: 0
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
RSV	RSV (AREXVY)	GLAXOSMITHKLINE BIOLOGICALS	1	255t2	—

Symptoms (1)

Incorrect dose administered

Symptom narrative

Partial dose with leakage; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of incomplete dose administered in a 86-year-old female patient who received RSVPreF3 adjuvanted (Arexvy) (batch number 255t2, expiry date 05-DEC-2025) for prophylaxis. On 10-MAR-2025, the patient received the 1st dose of Arexvy. On 10-MAR-2025, an unknown time after receiving Arexvy, the patient experienced incomplete dose administered (Verbatim: Partial dose with leakage). The outcome of the incomplete dose administered was not applicable. Additional Information: GSK Receipt Date: 10-MAR-2025 A pharmacist called in to request data about the need to readminister a dose of Arexvy after the patient was receiving a dose and recoiled, causing leakage of the vaccine, which led incomplete dose administered. The reporter consented to follow up.